BrafV600E Cooperates With Pten Loss to Induce Metastatic Melanoma

Nature Genetics - United Kingdom
doi 10.1038/ng.356
Full Text
Abstract

Available in full text

Categories
Genetics
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The FBXO4 Tumor Suppressor Functions as a Barrier to BrafV600E-Dependent Metastatic Melanoma

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2013English

MYC Activation Cooperates With VHL and Ink4a/Arf Loss to Induce Clear Cell Renal Cell Carcinoma

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

Id1 Cooperates With Oncogenic Ras to Induce Metastatic Mammary Carcinoma by Subversion of the Cellular Senescence Response

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Metastatic Tumor Dormancy in Cutaneous Melanoma: Does Surgery Induce Escape?

Cancers
Cancer ResearchOncology
2011English

Oncogenic BRAFV600E Inhibits BIM Expression to Promote Melanoma Cell Survival

Pigment Cell and Melanoma Research
BiochemistryDermatologyOncologyGeneticsMolecular Biology
2008English

PTEN Loss of Expression Predicts Cetuximab Efficacy in Metastatic Colorectal Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
2007English

The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response

Cancers
Cancer ResearchOncology
2020English

Grp94-Specific Monoclonal Antibody to Counteract BRAF Inhibitor Resistance in BRAFV600E Melanoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Ileoileal Intussusception Due to Metastatic Melanoma

Case Reports International
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy